Literature DB >> 17553917

Isolation and identification of phase 1 metabolites of demethoxycurcumin in rats.

Yongchi Zeng1, Feng Qiu, Yuan Liu, Gexia Qu, Xinsheng Yao.   

Abstract

Curcuminoids are a safe natural food coloring additive with anti-inflammatory, antioxidant, and anticarcinogenic activities. Although demethoxycurcumin is one of the major bioactive constituents of curcuminoids, knowledge about its metabolic fate is scant. In the present study, four new metabolites, 5-dehydroxy-hexahydro-demethoxycurcumin-A (M-1), 5-dehydroxy-hexahydro-demethoxycurcumin-B (M-2), 5-dehydroxy-octahydro-demethoxy-curcumin-A (M-3) and 5-dehydroxy-octahydro-demethoxycurcumin-B (M-4), were isolated from feces of male Wistar-derived rats and from urine; three new metabolites, 5-O-methyl-hexahydrodemethoxycurcumin-A (M-7), 5-O-methyl-hexahydro-demethoxycurcumin-B (M-8), and 5-dehydroxy-dihydro-demethoxycurcumin-B (M-9), and two known metabolites, hexahydro-demethoxycurcumin-A (M-5) and hexahydro-demethoxycurcumin-B (M-6), were isolated. Their structures were established by chemical and spectral methods. ll of them were reductive metabolites. Possibly of greater importance is that they occurred as pairs of isomers with a methoxyl group substituted on a different benzene ring. This finding in the metabolism of curcuminoids is reported here for the first time. In addition, the 5-dehydroxy or 5-O-methylated metabolites are also a novel finding. The fact that the metabolites occurred as pairs of the isomers suggests that demethoxycurcumin possibly undergoes tautomerization between 3-keto-5-enol (form A) and 3-keto-5-enol (form B) in rats. Based on the metabolite profiles, metabolic pathways of demethoxycurcumin in rats are proposed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553917     DOI: 10.1124/dmd.107.015008

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  Anti-inflammatory and Antioxidant Activity of Nanoencapsulated Curcuminoids Extracted from Curcuma longa L. in a Model of Cutaneous Inflammation.

Authors:  Emanuele P Lima; Odinei H Gonçalves; Franciele Q Ames; Lidiane V Castro-Hoshino; Fernanda V Leimann; Roberto K N Cuman; Jurandir F Comar; Ciomar A Bersani-Amado
Journal:  Inflammation       Date:  2020-11-09       Impact factor: 4.092

2.  Urinary metabolites of isorhynchophylline in rats and their neuroprotective activities in the HT22 cell assay.

Authors:  Fangfang Chen; Wen Qi; Jiahong Sun; James W Simpkins; Dan Yuan
Journal:  Fitoterapia       Date:  2014-06-06       Impact factor: 2.882

3.  Isolation and identification of twelve metabolites of isocorynoxeine in rat urine and their neuroprotective activities in HT22 cell assay.

Authors:  Wen Qi; Fangfang Chen; Jiahong Sun; James W Simpkins; Dan Yuan
Journal:  Planta Med       Date:  2014-12-17       Impact factor: 3.352

4.  Demethoxycurcumin Retards Cell Growth and Induces Apoptosis in Human Brain Malignant Glioma GBM 8401 Cells.

Authors:  Tzuu-Yuan Huang; Che-Wen Hsu; Weng-Cheng Chang; Miin-Yau Wang; June-Fu Wu; Yi-Chiang Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-15       Impact factor: 2.629

5.  Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1.

Authors:  Beibei Zhang; Jing Yang; Zifei Qin; Shishi Li; Jinjin Xu; Zhihong Yao; Xiaojian Zhang; Frank J Gonzalez; Xinsheng Yao
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

Review 6.  Curcumin, Gut Microbiota, and Neuroprotection.

Authors:  Francesco Di Meo; Sabrina Margarucci; Umberto Galderisi; Stefania Crispi; Gianfranco Peluso
Journal:  Nutrients       Date:  2019-10-11       Impact factor: 5.717

7.  Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.

Authors:  Jing Yang; Beibei Zhang; Zifei Qin; Shishi Li; Jinjin Xu; Zhihong Yao; Xiaojian Zhang; Frank J Gonzalez; Xinsheng Yao
Journal:  Biofactors       Date:  2018-10-17       Impact factor: 6.113

8.  HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study.

Authors:  Tao Yi; Lin Zhu; Guo-Yuan Zhu; Yi-Na Tang; Jun Xu; Jia-Yi Fan; Zhong-Zhen Zhao; Hu-Biao Chen
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.